welcome to the video journal of hematology & hematological oncology 🎥🩸
Published 4 months ago • 581 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
0:54
a research update in richter's transformation from ash 2023
-
1:05
the future of managing precursor conditions
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:46:07
hematology lecture
-
28:36
who myeloid neoplasms part 1 updates ii who hematology 5th e update ii review article (proposed)
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:41
an overview of the latest advances in hematology
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
11:42
thalassemia highlights at ash 2023: novel therapies, trial updates & the value of precision medicine
-
10:30
scd highlights at ash 2023: disease pathogenesis, ongoing clinical trials & novel gene therapies
-
1:32
factors contributing to the pathogenesis of icaht
-
1:02
novel agents in multiple myeloma: considering toxicity and side effects
-
3:34
the biological and psychological uncertainties in precursor disease